Expression of cytokeratin-19 as a marker of neoplastic progression of human prostate epithelial cells

Prostate

Volumn 35, Issue 3, 1998, Pages 203-211

  Prasad, S ^a,b   Thraves, P ^a   Dritschilo, A ^a   Kuettel, M ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2D PAGE; Cytokeratin 19; Intermediate filaments; Nuclear matrix; Prostate carcinogenesis; Radiation transformation

Indexed keywords

ACTIN BINDING PROTEIN; CYTOKERATIN 19;

ARTICLE; CANCER GRADING; CANCER STAGING; CELL SIZE; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IONIZING RADIATION; ONCOGENE RAS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROSTATE CANCER; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; EPITHELIAL CELLS; HUMANS; INTERMEDIATE FILAMENT PROTEINS; KERATINS; MALE; NUCLEAR MATRIX; NUCLEAR PROTEINS; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0032524949     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980515)35:3<203::AID-PROS6>3.0.CO;2-H     Document Type: Article

References (40)

1. Steinert PM, Roop DR: Molecular and cellular biology of intermediate filaments. Annu Rev Biochem 1988;57:593-625.
2. Fuchs E, Weber K: Intermediate filaments: Structure, dynamics, function and disease. Annu Rev Biochem 1994;63:345-382.
3. Yang L, Chew EC, Chew-Cheng SB, Jiao RJ, Yam HF, Zhai ZH: Fine structural observation of a nucleolar-nuclear matrix-lamina-intermediate filament system in transformed cells. Anticancer Res 1994;14:1829-1832.
4. Pellegrino MB, Asch BB, Connolly JL, Asch HL: Differential expression of keratins 13 and 16 in normal epithelium, benign lesions, and ductal carcinomas of the human breast determined by monoclonal antibody Ks8.12. Cancer Res 1988;48:5831-5836.
5. Khanuja PS, Lehr JE, Soule HD, Gehani SK, Noto AC, Choudhury S, Chen R, Pienta KJ: Nuclear matrix proteins in normal and breast cancer cells. Cancer Res 1993;53:3394-3398.
6. Trask DK, Band V, Zajchowski DA, Yaswen P, Suh T, Sager P: Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells. Proc Natl Acad Sci USA 1990;87: 2319-2323.
7. Getzenberg RH, Pienta KJ, Huang EY, Coffey DS: Identification of nuclear matrix proteins in the cancer and normal prostate. Cancer Res 1991;51:6514-6520.
8. Partin AW, Getzenberg RH, Carmichael MJ, Vindivich D, Yoo J, Epstein JI, Coffey DS: Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. Cancer Res 1993;53:744-746.
9. Sherwood ER, Berg LA, McEwan RN, Pasciak RM, Kozlowski JM, Lee C: Two-dimensional protein profiles of cultured stromal and epithelial cells from hyperplastic human prostate. J Cell Biochem 1989;40:201-214.
10. Brawer MK, Peehl DM, Stamey TA, Bostwick DG: Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res 1985;45:3663-3667.
11. Nagle RB, Ahmann FR, McDaniel KM, Paquin ML, Clark VA, Celniker A: Cytokeratin characterization of human prostatic carcinoma and its derived cell lines. Cancer Res 1987;47:281-286.
12. Peehl DM, Leung GK, Wong ST: Keratin expression: A measure of phenotypic modulation of human prostatic epithelial cells by growth inhibitory factors. Cell Tissue Res 1994;277:11-18.
13. Fey EG, Wan KM, Penman S: Epithelial cytoskeletal framework and nuclear matrix-intermediate filament scaffold: Three-dimensional organization and protein composition. J Cell Biol 1984;98:1973-1984.
14. Moll R, Franke WW, Schiller DL: The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
15. Osborn M, Weber K: Tumor diagnosis by intermediate filament typing: A novel tool for surgical pathology. Lab Invest 1993;48: 372-394.
16. Nagle RB: A review of intermediate filament biology and their use in pathologic diagnosis. Mol Biol Rep 1994;19:3-21.
17. Chou Y, Skalli O, Goldman RD: Intermediate filaments and cytoplasmic networking: New connections and more functions. Curr Opin Cell Biol 1997;9:49-54.
18. Green K, Jones JC: Desmosomes and hemidesmosomes: Structure and function of molecular components. FASEB J 1996;10: 871-881.
19. Nan L, Kawamata H, Tan X, Kameyama S, Oyasu R: Differential expression of keratin 5 gene in non-tumorigenic and tumorigenic rat bladder cell lines. Cancer Lett 1993;75:87-93.
20. Pujol J-L, Grenier J, Daures J-P, Daver A, Pujol H, Michel F-B: Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res 1993;53:61-66.
21. Peehl DM, Sellers RG, McNeal JE: Keratin 19 in the adult human prostate: Tissue and cell culture studies. Cell Tissue Res 1996; 285:171-176.
22. Nagle RB: Intermediate filament expression in prostate cancer. Cancer Metastasis Rev 1996;15:473-482.
23. Oshima RG, Baribault H, Caulin C: Oncogenic regulation and function of keratins 8 and 18. Cancer Metastasis Rev 1996;15: 445-471.
24. Kuettel MR, Thraves PJ, Jung M, Varghese SP, Prasad SC, Rhim JS, Dritschilo A: Radiation-induced neoplastic transformation of human prostrate epithelial cells. Cancer Res 1996;56:5-10.
25. Kuettel MR, Jung M, Thraves P, Prasad SC, Varghese S, Rhim JS, Dritschilo A: Human prostate epithelial cell model system for carcinogenic studies. Radiat Oncol Invest 1996;3:340-345.
26. Prasad SC, Thraves PJ, Dritscilo A, Rhim JS, Kuettel MK: Cytoskeletal changes during radiation-induced neoplastic transformation of human prostate epithelial cells. Scanning Microsc 1998; (in press).
27. Prasad SC, Thraves PJ, Dritschilo A, Kuettel MK: Protein expression changes associated with radiation-induced neoplastic progression of human prostate epithelial cells. Electrophoresis 1997;18:629-637.
28. Parda DS, Thraves PJ, Kuettel MR, Lee MS, Arnstein P, Kaighn ME, Rhim JS, Dritschilo A: Neoplastic transformation of a human prostate epithelial cell line by the v-Ki-ras oncogene. Prostate 1993;23:91-98.
29. O'Farrel PH: High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975;250:4007-4021.
30. Celis JE, Rasmussen HH, Gromov P, Olsen E, Madsen P, Leffers H, Honore B, Dejgaard K, Vorum H, Kristensen DB, Ostergaard M, Hanuso A, Jensen NA, Celis A, Basse B, Lawridsen JB, Ratz GP, Anderson AH, Walbam E, Kjaergaard I, Andersen I, Pupype M, Van Damme JV, Vanderkerekhove J: The human keratinocyte two-dimensional gel protein database (update 1995): Major components of signal transduction pathways. Electrophoresis 1995;16:2177-2240.
31. Weber MM, Bello D, Quader S: Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications. Part 2. Tumorigenic cell lines. Prostate 1997;30:58-64.
32. Prasad SC, Dritschilo A, Rhim J, Worland P, Thraves P: Protein expression patterns of radiation transformed human epidermal keratinocytes: A two-dimensional gel electrophoretic approach. Radiat Oncol Invest 1994;1:314-324.
33. Desaintes C, Hallez S, Detremmerie O, Burny A: Wild-type p53 down-regulates transcription from oncogenic human papillomavirus promoters through the epithelial specific enhancer. Oncogene 1995;10:2155-2161.
34. Moles JP, Schiller JT, Tesniere A, Leigh IM, Guilhou JJ, Basset-Seguin N: Analysis of HPV16 E6 and mutant p53-transfected keratinocytes in reconstituted epidermis suggests that wild-type p53 inhibits cytokeratin 19 expression. J Cell Sci 1994;107:435-441.
35. Isaacs WB, Carter BS, and Ewing CM: Wild type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res 1991;51:4716-4720.
36. Chi SG, deVerse RW, Meyers FJ, Siders DG, Lee F, Gumerlock PH: p53 in prostate cancer: Frequent expressed transition mutations. J Natl Cancer Inst 1994;86:926-933.
37. Takada M, Masuda E, Kusunoki Y, Matui K, Nakagawa K, Yana T, Tuyuguchi I, Oohata I, Fukuoka M: Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay. Br J Cancer 1995;71:160-165.
38. Chan R, Rossitto PV, Edwards BF, Cardiff RD: Presence of proteolytically processed variants in the culture medium of MCF-7 cells. Cancer Res 1986;46:6353-6359.
39. Bader BL, Magin TM, Freudenmann M, Stumpp S, Franke WW: Intermediate filaments formed de novo from tail-less cytokeratins in the cytoplasm and in the nucleus. J Cell Biol 1991;115: 1293-1307.
40. Crowe DL: Retinoic acid mediates post-transcriptional regulation of keratin 19 mRNA levels. J Cell Sci 1993;106:183-188.